ANIX
Anixa Biosciences Inc

10,547
Mkt Cap
$107.47M
Volume
1,577.00
52W High
$5.46
52W Low
$2.33
PE Ratio
-9.56
ANIX Fundamentals
Price
$3.22
Prev Close
$3.31
Open
$3.33
50D MA
$3.92
Beta
1.16
Avg. Volume
510,688.32
EPS (Annual)
-$0.3367
P/B
7.01
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Anixa Biosciences (NASDAQ:ANIX) Issues Earnings Results, Meets Expectations
Anixa Biosciences (NASDAQ:ANIX - Get Free Report) posted its earnings results on Monday. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Brokerages
Shares of Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) have been assigned an average rating of "Hold" from the five brokerages that are currently covering the stock, MarketBeat Ratings...
MarketBeat·11d ago
News Placeholder
Anixa Biosciences (ANIX) Expected to Announce Quarterly Earnings on Friday
Anixa Biosciences (NASDAQ:ANIX) will be releasing its Q4 2025 earnings before the market opens on Friday, January 9. (View Earnings Report at...
MarketBeat·14d ago
News Placeholder
Anixa Biosciences Inc (NASDAQ:ANIX) Sees Significant Increase in Short Interest
Anixa Biosciences Inc (NASDAQ:ANIX - Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totaling 795,400 shares, an increase of 40.7...
MarketBeat·18d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded shares of Anixa Biosciences from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·20d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at D. Boral Capital
D. Boral Capital reaffirmed a "buy" rating and issued a $10.00 price target on shares of Anixa Biosciences in a research note on Friday...
MarketBeat·1mo ago
News Placeholder
Anixa Biosciences Shares Jump Over 15% In After-Hours Trading Here's Why
Anixa Biosciences shares surged in after-hours trading after presenting clinical trial data for its investigational breast cancer vaccine.read more...
Benzinga·1mo ago
News Placeholder
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants Anixa Biosciences Announces...
PR Newswire·1mo ago
News Placeholder
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025...
PR Newswire·1mo ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research
Zacks Research downgraded Anixa Biosciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday...
MarketBeat·2mo ago
<
1
2
...
>

Latest ANIX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.